Pulsenmore Ltd. (PLSM)

NASDAQ: PLSM · Real-Time Price · USD
3.590
+0.240 (7.16%)
At close: Apr 10, 2026, 4:00 PM EDT
3.360
-0.230 (-6.41%)
After-hours: Apr 10, 2026, 4:00 PM EDT
Market Cap22.37M -46.0%
Revenue (ttm)12.55M +314.3%
Net Income-4.97M
EPS-0.77
Shares Out 6.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,971
Open3.400
Previous Close3.350
Day's Range3.400 - 3.930
52-Week Range3.000 - 10.280
Beta0.23
Analystsn/a
Price Targetn/a
Earnings DateMar 30, 2026

About PLSM

Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.

Sector Healthcare
Founded 2014
Employees 71
Stock Exchange NASDAQ
Ticker Symbol PLSM
Full Company Profile

Financial Performance

In 2025, Pulsenmore's revenue was 40.02 million, an increase of 314.28% compared to the previous year's 9.66 million. Losses were -15.85 million, -56.85% less than in 2024.

Financial numbers in ILS Financial Statements

News

Pulsenmore Announces Full Year 2025 Financial Results and Webcast

Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update OMER, Israel, March 30, 2026  /PRNewswire/ – Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM...

13 days ago - PRNewsWire

Pulsenmore Announces Full Year 2025 Earnings Conference Call

OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full y...

18 days ago - PRNewsWire

Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance

OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a ma...

2 months ago - PRNewsWire

Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center

OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in ...

2 months ago - PRNewsWire

Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation

Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be deployed via Beilinson NEXT, Beilinson's virtual hospital RAMAT GAN, Israe...

2 months ago - PRNewsWire

Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.

RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd.  (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at ...

2 months ago - PRNewsWire